Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study
Aim This study aims to examine the real‐world effectiveness of education regarding clinical guidelines for psychiatric disorders using ‘the Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)’ project. Methods The EGUIDE project is a nationwide prospective i...
Gespeichert in:
Veröffentlicht in: | Psychiatry and clinical neurosciences 2023-10, Vol.77 (10), p.559-568 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 568 |
---|---|
container_issue | 10 |
container_start_page | 559 |
container_title | Psychiatry and clinical neurosciences |
container_volume | 77 |
creator | Hasegawa, Naomi Yasuda, Yuka Yasui‐Furukori, Norio Yamada, Hisashi Hori, Hikaru Ichihashi, Kayo Takaesu, Yoshikazu Iida, Hitoshi Muraoka, Hiroyuki Kodaka, Fumitoshi Iga, Jun‐ichi Hashimoto, Naoki Ogasawara, Kazuyoshi Ohi, Kazutaka Fukumoto, Kentaro Numata, Shusuke Tsuboi, Takashi Usami, Masahide Hishimoto, Akitoyo Furihata, Ryuji Kishimoto, Taishiro Nakamura, Toshinori Katsumoto, Eiichi Ochi, Shinichiro Nagasawa, Tatsuya Atake, Kiyokazu Kubota, Chika Komatsu, Hiroshi Yamagata, Hirotaka Ide, Kenta Takeshima, Masahiro Kido, Mikio Kikuchi, Saya Okada, Tsuyoshi Matsumoto, Junya Miura, Kenichiro Shimazu, Taichi Inada, Ken Watanabe, Koichiro Hashimoto, Ryota |
description | Aim
This study aims to examine the real‐world effectiveness of education regarding clinical guidelines for psychiatric disorders using ‘the Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)’ project.
Methods
The EGUIDE project is a nationwide prospective implementation study of two clinical practice guidelines, i.e., the Guideline for Pharmacological Therapy of Schizophrenia and the Treatment Guidelines for Major Depressive Disorders, in Japan. Between 2016 and 2019, 782 psychiatrists belonging to 176 hospitals with psychiatric wards participated in the project and attended lectures on clinical practice guidelines. The proportions of guideline‐recommended treatments in 7405 patients with schizophrenia and 3794 patients with major depressive disorder at participating hospitals were compared between patients under the care of psychiatrists participating in the project and those not participating in the project. Clinical and prescribing data on the patients discharged from April to September each year from participating hospitals of the project were also analyzed.
Results
The proportions of three quality indicators (antipsychotic monotherapy regardless of whether other psychotropics medication, antipsychotic monotherapy without other psychotropics and no prescription of anxiolytics or hypnotics) for schizophrenia were higher among participating psychiatrists than among nonparticipating psychiatrists. As similar results were obtained in major depressive disorder, the effectiveness of the project for the dissemination of guideline‐recommended treatment has been replicated.
Conclusion
This strategy of providing education regarding the clinical guidelines for psychiatric disorders was effective in improving the treatment‐related behavior of psychiatrists. The use of this education‐based strategy might contribute to resolving the mental health treatment gap. |
doi_str_mv | 10.1111/pcn.13578 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11488608</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2863294868</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5548-b615fca94941a3b6e943133bd1480c9306d7a549656a672718d7b449bf0b067e3</originalsourceid><addsrcrecordid>eNp1kc9uFSEYxSdGY2t14QsYEje6mBYGBhg3TXNT_ySNutA1YeCbOzRzYQSm5voavrCMtzbVREICCb9zvkNOVT0n-JSUdTYbf0poK-SD6pgwhmsiSfew3GlDa0IJP6qepHSNMaaUk8fVERVcMkHIcfXzchjAZBQGBHYxOrvgUYStjtb5LcoRdN6Bz2i7OAuT85DQECJKZnQ_wjxG8E4j7S2yMEdIadWXnUe4J-5h1DeuyMqYOe2LVufoUk5v0AXaLVN2pmBQbPNi90-rR4OeEjy7PU-qr28vv2ze11ef3n3YXFzVpm2ZrHtO2sHojnWMaNpz6BgllPaWMIlNRzG3Qres4y3XXDSCSCt6xrp-wD3mAuhJdX7wnZd-B3aNEPWk5uh2Ou5V0E79_eLdqLbhRpEyQXIsi8OrW4cYvi2Qstq5ZGCatIewJNVITpuOSb6iL_9Br8MSfflfoUSDBcFypV4fKBNDShGGuzQEq7VrVbpWv7su7Iv78e_IP-UW4OwAfHcT7P_vpD5vPh4sfwFWfbaj</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2872071088</pqid></control><display><type>article</type><title>Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study</title><source>Wiley Online Library - AutoHoldings Journals</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Open Access Titles of Japan</source><source>Wiley Online Library (Open Access Collection)</source><creator>Hasegawa, Naomi ; Yasuda, Yuka ; Yasui‐Furukori, Norio ; Yamada, Hisashi ; Hori, Hikaru ; Ichihashi, Kayo ; Takaesu, Yoshikazu ; Iida, Hitoshi ; Muraoka, Hiroyuki ; Kodaka, Fumitoshi ; Iga, Jun‐ichi ; Hashimoto, Naoki ; Ogasawara, Kazuyoshi ; Ohi, Kazutaka ; Fukumoto, Kentaro ; Numata, Shusuke ; Tsuboi, Takashi ; Usami, Masahide ; Hishimoto, Akitoyo ; Furihata, Ryuji ; Kishimoto, Taishiro ; Nakamura, Toshinori ; Katsumoto, Eiichi ; Ochi, Shinichiro ; Nagasawa, Tatsuya ; Atake, Kiyokazu ; Kubota, Chika ; Komatsu, Hiroshi ; Yamagata, Hirotaka ; Ide, Kenta ; Takeshima, Masahiro ; Kido, Mikio ; Kikuchi, Saya ; Okada, Tsuyoshi ; Matsumoto, Junya ; Miura, Kenichiro ; Shimazu, Taichi ; Inada, Ken ; Watanabe, Koichiro ; Hashimoto, Ryota</creator><creatorcontrib>Hasegawa, Naomi ; Yasuda, Yuka ; Yasui‐Furukori, Norio ; Yamada, Hisashi ; Hori, Hikaru ; Ichihashi, Kayo ; Takaesu, Yoshikazu ; Iida, Hitoshi ; Muraoka, Hiroyuki ; Kodaka, Fumitoshi ; Iga, Jun‐ichi ; Hashimoto, Naoki ; Ogasawara, Kazuyoshi ; Ohi, Kazutaka ; Fukumoto, Kentaro ; Numata, Shusuke ; Tsuboi, Takashi ; Usami, Masahide ; Hishimoto, Akitoyo ; Furihata, Ryuji ; Kishimoto, Taishiro ; Nakamura, Toshinori ; Katsumoto, Eiichi ; Ochi, Shinichiro ; Nagasawa, Tatsuya ; Atake, Kiyokazu ; Kubota, Chika ; Komatsu, Hiroshi ; Yamagata, Hirotaka ; Ide, Kenta ; Takeshima, Masahiro ; Kido, Mikio ; Kikuchi, Saya ; Okada, Tsuyoshi ; Matsumoto, Junya ; Miura, Kenichiro ; Shimazu, Taichi ; Inada, Ken ; Watanabe, Koichiro ; Hashimoto, Ryota</creatorcontrib><description>Aim
This study aims to examine the real‐world effectiveness of education regarding clinical guidelines for psychiatric disorders using ‘the Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)’ project.
Methods
The EGUIDE project is a nationwide prospective implementation study of two clinical practice guidelines, i.e., the Guideline for Pharmacological Therapy of Schizophrenia and the Treatment Guidelines for Major Depressive Disorders, in Japan. Between 2016 and 2019, 782 psychiatrists belonging to 176 hospitals with psychiatric wards participated in the project and attended lectures on clinical practice guidelines. The proportions of guideline‐recommended treatments in 7405 patients with schizophrenia and 3794 patients with major depressive disorder at participating hospitals were compared between patients under the care of psychiatrists participating in the project and those not participating in the project. Clinical and prescribing data on the patients discharged from April to September each year from participating hospitals of the project were also analyzed.
Results
The proportions of three quality indicators (antipsychotic monotherapy regardless of whether other psychotropics medication, antipsychotic monotherapy without other psychotropics and no prescription of anxiolytics or hypnotics) for schizophrenia were higher among participating psychiatrists than among nonparticipating psychiatrists. As similar results were obtained in major depressive disorder, the effectiveness of the project for the dissemination of guideline‐recommended treatment has been replicated.
Conclusion
This strategy of providing education regarding the clinical guidelines for psychiatric disorders was effective in improving the treatment‐related behavior of psychiatrists. The use of this education‐based strategy might contribute to resolving the mental health treatment gap.</description><identifier>ISSN: 1323-1316</identifier><identifier>ISSN: 1440-1819</identifier><identifier>EISSN: 1440-1819</identifier><identifier>DOI: 10.1111/pcn.13578</identifier><identifier>PMID: 37684711</identifier><language>eng</language><publisher>Melbourne: John Wiley & Sons Australia, Ltd</publisher><subject>Antipsychotic Agents - therapeutic use ; Antipsychotics ; Anxiolytics ; Clinical medicine ; clinical practice guideline ; Clinical practice guidelines ; Depression ; Depressive Disorder, Major - drug therapy ; dissemination ; education ; Hospitals ; Humans ; Hypnotics ; major depressive disorder ; Mental depression ; Mental disorders ; Patients ; Prospective Studies ; Psychiatrists ; Psychiatry ; Psychotropic drugs ; Psychotropic Drugs - therapeutic use ; Regular ; Schizophrenia ; Schizophrenia - drug therapy</subject><ispartof>Psychiatry and clinical neurosciences, 2023-10, Vol.77 (10), p.559-568</ispartof><rights>2023 The Authors. published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology.</rights><rights>2023 The Authors. Psychiatry and Clinical Neurosciences published by John Wiley & Sons Australia, Ltd on behalf of Japanese Society of Psychiatry and Neurology.</rights><rights>2023. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5548-b615fca94941a3b6e943133bd1480c9306d7a549656a672718d7b449bf0b067e3</citedby><cites>FETCH-LOGICAL-c5548-b615fca94941a3b6e943133bd1480c9306d7a549656a672718d7b449bf0b067e3</cites><orcidid>0000-0002-3722-7837 ; 0000-0002-8253-8888 ; 0000-0001-8311-7148 ; 0000-0002-4414-3770 ; 0000-0002-9169-3249 ; 0000-0003-4228-3208 ; 0000-0002-3073-4588 ; 0000-0002-1145-9971 ; 0000-0002-2746-1590 ; 0000-0003-0614-7524 ; 0000-0002-0736-7070 ; 0000-0001-9417-4391 ; 0000-0003-2263-3477 ; 0000-0002-0809-2697 ; 0000-0002-5941-4238 ; 0000-0001-9577-9640 ; 0000-0001-8129-4220 ; 0000-0003-4409-3096 ; 0000-0002-2240-5290</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fpcn.13578$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fpcn.13578$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>230,315,782,786,887,1419,1435,27931,27932,45581,45582,46416,46840</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37684711$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hasegawa, Naomi</creatorcontrib><creatorcontrib>Yasuda, Yuka</creatorcontrib><creatorcontrib>Yasui‐Furukori, Norio</creatorcontrib><creatorcontrib>Yamada, Hisashi</creatorcontrib><creatorcontrib>Hori, Hikaru</creatorcontrib><creatorcontrib>Ichihashi, Kayo</creatorcontrib><creatorcontrib>Takaesu, Yoshikazu</creatorcontrib><creatorcontrib>Iida, Hitoshi</creatorcontrib><creatorcontrib>Muraoka, Hiroyuki</creatorcontrib><creatorcontrib>Kodaka, Fumitoshi</creatorcontrib><creatorcontrib>Iga, Jun‐ichi</creatorcontrib><creatorcontrib>Hashimoto, Naoki</creatorcontrib><creatorcontrib>Ogasawara, Kazuyoshi</creatorcontrib><creatorcontrib>Ohi, Kazutaka</creatorcontrib><creatorcontrib>Fukumoto, Kentaro</creatorcontrib><creatorcontrib>Numata, Shusuke</creatorcontrib><creatorcontrib>Tsuboi, Takashi</creatorcontrib><creatorcontrib>Usami, Masahide</creatorcontrib><creatorcontrib>Hishimoto, Akitoyo</creatorcontrib><creatorcontrib>Furihata, Ryuji</creatorcontrib><creatorcontrib>Kishimoto, Taishiro</creatorcontrib><creatorcontrib>Nakamura, Toshinori</creatorcontrib><creatorcontrib>Katsumoto, Eiichi</creatorcontrib><creatorcontrib>Ochi, Shinichiro</creatorcontrib><creatorcontrib>Nagasawa, Tatsuya</creatorcontrib><creatorcontrib>Atake, Kiyokazu</creatorcontrib><creatorcontrib>Kubota, Chika</creatorcontrib><creatorcontrib>Komatsu, Hiroshi</creatorcontrib><creatorcontrib>Yamagata, Hirotaka</creatorcontrib><creatorcontrib>Ide, Kenta</creatorcontrib><creatorcontrib>Takeshima, Masahiro</creatorcontrib><creatorcontrib>Kido, Mikio</creatorcontrib><creatorcontrib>Kikuchi, Saya</creatorcontrib><creatorcontrib>Okada, Tsuyoshi</creatorcontrib><creatorcontrib>Matsumoto, Junya</creatorcontrib><creatorcontrib>Miura, Kenichiro</creatorcontrib><creatorcontrib>Shimazu, Taichi</creatorcontrib><creatorcontrib>Inada, Ken</creatorcontrib><creatorcontrib>Watanabe, Koichiro</creatorcontrib><creatorcontrib>Hashimoto, Ryota</creatorcontrib><title>Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study</title><title>Psychiatry and clinical neurosciences</title><addtitle>Psychiatry Clin Neurosci</addtitle><description>Aim
This study aims to examine the real‐world effectiveness of education regarding clinical guidelines for psychiatric disorders using ‘the Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)’ project.
Methods
The EGUIDE project is a nationwide prospective implementation study of two clinical practice guidelines, i.e., the Guideline for Pharmacological Therapy of Schizophrenia and the Treatment Guidelines for Major Depressive Disorders, in Japan. Between 2016 and 2019, 782 psychiatrists belonging to 176 hospitals with psychiatric wards participated in the project and attended lectures on clinical practice guidelines. The proportions of guideline‐recommended treatments in 7405 patients with schizophrenia and 3794 patients with major depressive disorder at participating hospitals were compared between patients under the care of psychiatrists participating in the project and those not participating in the project. Clinical and prescribing data on the patients discharged from April to September each year from participating hospitals of the project were also analyzed.
Results
The proportions of three quality indicators (antipsychotic monotherapy regardless of whether other psychotropics medication, antipsychotic monotherapy without other psychotropics and no prescription of anxiolytics or hypnotics) for schizophrenia were higher among participating psychiatrists than among nonparticipating psychiatrists. As similar results were obtained in major depressive disorder, the effectiveness of the project for the dissemination of guideline‐recommended treatment has been replicated.
Conclusion
This strategy of providing education regarding the clinical guidelines for psychiatric disorders was effective in improving the treatment‐related behavior of psychiatrists. The use of this education‐based strategy might contribute to resolving the mental health treatment gap.</description><subject>Antipsychotic Agents - therapeutic use</subject><subject>Antipsychotics</subject><subject>Anxiolytics</subject><subject>Clinical medicine</subject><subject>clinical practice guideline</subject><subject>Clinical practice guidelines</subject><subject>Depression</subject><subject>Depressive Disorder, Major - drug therapy</subject><subject>dissemination</subject><subject>education</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Hypnotics</subject><subject>major depressive disorder</subject><subject>Mental depression</subject><subject>Mental disorders</subject><subject>Patients</subject><subject>Prospective Studies</subject><subject>Psychiatrists</subject><subject>Psychiatry</subject><subject>Psychotropic drugs</subject><subject>Psychotropic Drugs - therapeutic use</subject><subject>Regular</subject><subject>Schizophrenia</subject><subject>Schizophrenia - drug therapy</subject><issn>1323-1316</issn><issn>1440-1819</issn><issn>1440-1819</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>EIF</sourceid><recordid>eNp1kc9uFSEYxSdGY2t14QsYEje6mBYGBhg3TXNT_ySNutA1YeCbOzRzYQSm5voavrCMtzbVREICCb9zvkNOVT0n-JSUdTYbf0poK-SD6pgwhmsiSfew3GlDa0IJP6qepHSNMaaUk8fVERVcMkHIcfXzchjAZBQGBHYxOrvgUYStjtb5LcoRdN6Bz2i7OAuT85DQECJKZnQ_wjxG8E4j7S2yMEdIadWXnUe4J-5h1DeuyMqYOe2LVufoUk5v0AXaLVN2pmBQbPNi90-rR4OeEjy7PU-qr28vv2ze11ef3n3YXFzVpm2ZrHtO2sHojnWMaNpz6BgllPaWMIlNRzG3Qres4y3XXDSCSCt6xrp-wD3mAuhJdX7wnZd-B3aNEPWk5uh2Ou5V0E79_eLdqLbhRpEyQXIsi8OrW4cYvi2Qstq5ZGCatIewJNVITpuOSb6iL_9Br8MSfflfoUSDBcFypV4fKBNDShGGuzQEq7VrVbpWv7su7Iv78e_IP-UW4OwAfHcT7P_vpD5vPh4sfwFWfbaj</recordid><startdate>202310</startdate><enddate>202310</enddate><creator>Hasegawa, Naomi</creator><creator>Yasuda, Yuka</creator><creator>Yasui‐Furukori, Norio</creator><creator>Yamada, Hisashi</creator><creator>Hori, Hikaru</creator><creator>Ichihashi, Kayo</creator><creator>Takaesu, Yoshikazu</creator><creator>Iida, Hitoshi</creator><creator>Muraoka, Hiroyuki</creator><creator>Kodaka, Fumitoshi</creator><creator>Iga, Jun‐ichi</creator><creator>Hashimoto, Naoki</creator><creator>Ogasawara, Kazuyoshi</creator><creator>Ohi, Kazutaka</creator><creator>Fukumoto, Kentaro</creator><creator>Numata, Shusuke</creator><creator>Tsuboi, Takashi</creator><creator>Usami, Masahide</creator><creator>Hishimoto, Akitoyo</creator><creator>Furihata, Ryuji</creator><creator>Kishimoto, Taishiro</creator><creator>Nakamura, Toshinori</creator><creator>Katsumoto, Eiichi</creator><creator>Ochi, Shinichiro</creator><creator>Nagasawa, Tatsuya</creator><creator>Atake, Kiyokazu</creator><creator>Kubota, Chika</creator><creator>Komatsu, Hiroshi</creator><creator>Yamagata, Hirotaka</creator><creator>Ide, Kenta</creator><creator>Takeshima, Masahiro</creator><creator>Kido, Mikio</creator><creator>Kikuchi, Saya</creator><creator>Okada, Tsuyoshi</creator><creator>Matsumoto, Junya</creator><creator>Miura, Kenichiro</creator><creator>Shimazu, Taichi</creator><creator>Inada, Ken</creator><creator>Watanabe, Koichiro</creator><creator>Hashimoto, Ryota</creator><general>John Wiley & Sons Australia, Ltd</general><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-3722-7837</orcidid><orcidid>https://orcid.org/0000-0002-8253-8888</orcidid><orcidid>https://orcid.org/0000-0001-8311-7148</orcidid><orcidid>https://orcid.org/0000-0002-4414-3770</orcidid><orcidid>https://orcid.org/0000-0002-9169-3249</orcidid><orcidid>https://orcid.org/0000-0003-4228-3208</orcidid><orcidid>https://orcid.org/0000-0002-3073-4588</orcidid><orcidid>https://orcid.org/0000-0002-1145-9971</orcidid><orcidid>https://orcid.org/0000-0002-2746-1590</orcidid><orcidid>https://orcid.org/0000-0003-0614-7524</orcidid><orcidid>https://orcid.org/0000-0002-0736-7070</orcidid><orcidid>https://orcid.org/0000-0001-9417-4391</orcidid><orcidid>https://orcid.org/0000-0003-2263-3477</orcidid><orcidid>https://orcid.org/0000-0002-0809-2697</orcidid><orcidid>https://orcid.org/0000-0002-5941-4238</orcidid><orcidid>https://orcid.org/0000-0001-9577-9640</orcidid><orcidid>https://orcid.org/0000-0001-8129-4220</orcidid><orcidid>https://orcid.org/0000-0003-4409-3096</orcidid><orcidid>https://orcid.org/0000-0002-2240-5290</orcidid></search><sort><creationdate>202310</creationdate><title>Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study</title><author>Hasegawa, Naomi ; Yasuda, Yuka ; Yasui‐Furukori, Norio ; Yamada, Hisashi ; Hori, Hikaru ; Ichihashi, Kayo ; Takaesu, Yoshikazu ; Iida, Hitoshi ; Muraoka, Hiroyuki ; Kodaka, Fumitoshi ; Iga, Jun‐ichi ; Hashimoto, Naoki ; Ogasawara, Kazuyoshi ; Ohi, Kazutaka ; Fukumoto, Kentaro ; Numata, Shusuke ; Tsuboi, Takashi ; Usami, Masahide ; Hishimoto, Akitoyo ; Furihata, Ryuji ; Kishimoto, Taishiro ; Nakamura, Toshinori ; Katsumoto, Eiichi ; Ochi, Shinichiro ; Nagasawa, Tatsuya ; Atake, Kiyokazu ; Kubota, Chika ; Komatsu, Hiroshi ; Yamagata, Hirotaka ; Ide, Kenta ; Takeshima, Masahiro ; Kido, Mikio ; Kikuchi, Saya ; Okada, Tsuyoshi ; Matsumoto, Junya ; Miura, Kenichiro ; Shimazu, Taichi ; Inada, Ken ; Watanabe, Koichiro ; Hashimoto, Ryota</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5548-b615fca94941a3b6e943133bd1480c9306d7a549656a672718d7b449bf0b067e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Antipsychotic Agents - therapeutic use</topic><topic>Antipsychotics</topic><topic>Anxiolytics</topic><topic>Clinical medicine</topic><topic>clinical practice guideline</topic><topic>Clinical practice guidelines</topic><topic>Depression</topic><topic>Depressive Disorder, Major - drug therapy</topic><topic>dissemination</topic><topic>education</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Hypnotics</topic><topic>major depressive disorder</topic><topic>Mental depression</topic><topic>Mental disorders</topic><topic>Patients</topic><topic>Prospective Studies</topic><topic>Psychiatrists</topic><topic>Psychiatry</topic><topic>Psychotropic drugs</topic><topic>Psychotropic Drugs - therapeutic use</topic><topic>Regular</topic><topic>Schizophrenia</topic><topic>Schizophrenia - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hasegawa, Naomi</creatorcontrib><creatorcontrib>Yasuda, Yuka</creatorcontrib><creatorcontrib>Yasui‐Furukori, Norio</creatorcontrib><creatorcontrib>Yamada, Hisashi</creatorcontrib><creatorcontrib>Hori, Hikaru</creatorcontrib><creatorcontrib>Ichihashi, Kayo</creatorcontrib><creatorcontrib>Takaesu, Yoshikazu</creatorcontrib><creatorcontrib>Iida, Hitoshi</creatorcontrib><creatorcontrib>Muraoka, Hiroyuki</creatorcontrib><creatorcontrib>Kodaka, Fumitoshi</creatorcontrib><creatorcontrib>Iga, Jun‐ichi</creatorcontrib><creatorcontrib>Hashimoto, Naoki</creatorcontrib><creatorcontrib>Ogasawara, Kazuyoshi</creatorcontrib><creatorcontrib>Ohi, Kazutaka</creatorcontrib><creatorcontrib>Fukumoto, Kentaro</creatorcontrib><creatorcontrib>Numata, Shusuke</creatorcontrib><creatorcontrib>Tsuboi, Takashi</creatorcontrib><creatorcontrib>Usami, Masahide</creatorcontrib><creatorcontrib>Hishimoto, Akitoyo</creatorcontrib><creatorcontrib>Furihata, Ryuji</creatorcontrib><creatorcontrib>Kishimoto, Taishiro</creatorcontrib><creatorcontrib>Nakamura, Toshinori</creatorcontrib><creatorcontrib>Katsumoto, Eiichi</creatorcontrib><creatorcontrib>Ochi, Shinichiro</creatorcontrib><creatorcontrib>Nagasawa, Tatsuya</creatorcontrib><creatorcontrib>Atake, Kiyokazu</creatorcontrib><creatorcontrib>Kubota, Chika</creatorcontrib><creatorcontrib>Komatsu, Hiroshi</creatorcontrib><creatorcontrib>Yamagata, Hirotaka</creatorcontrib><creatorcontrib>Ide, Kenta</creatorcontrib><creatorcontrib>Takeshima, Masahiro</creatorcontrib><creatorcontrib>Kido, Mikio</creatorcontrib><creatorcontrib>Kikuchi, Saya</creatorcontrib><creatorcontrib>Okada, Tsuyoshi</creatorcontrib><creatorcontrib>Matsumoto, Junya</creatorcontrib><creatorcontrib>Miura, Kenichiro</creatorcontrib><creatorcontrib>Shimazu, Taichi</creatorcontrib><creatorcontrib>Inada, Ken</creatorcontrib><creatorcontrib>Watanabe, Koichiro</creatorcontrib><creatorcontrib>Hashimoto, Ryota</creatorcontrib><collection>Wiley Online Library (Open Access Collection)</collection><collection>Wiley Online Library (Open Access Collection)</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Psychiatry and clinical neurosciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hasegawa, Naomi</au><au>Yasuda, Yuka</au><au>Yasui‐Furukori, Norio</au><au>Yamada, Hisashi</au><au>Hori, Hikaru</au><au>Ichihashi, Kayo</au><au>Takaesu, Yoshikazu</au><au>Iida, Hitoshi</au><au>Muraoka, Hiroyuki</au><au>Kodaka, Fumitoshi</au><au>Iga, Jun‐ichi</au><au>Hashimoto, Naoki</au><au>Ogasawara, Kazuyoshi</au><au>Ohi, Kazutaka</au><au>Fukumoto, Kentaro</au><au>Numata, Shusuke</au><au>Tsuboi, Takashi</au><au>Usami, Masahide</au><au>Hishimoto, Akitoyo</au><au>Furihata, Ryuji</au><au>Kishimoto, Taishiro</au><au>Nakamura, Toshinori</au><au>Katsumoto, Eiichi</au><au>Ochi, Shinichiro</au><au>Nagasawa, Tatsuya</au><au>Atake, Kiyokazu</au><au>Kubota, Chika</au><au>Komatsu, Hiroshi</au><au>Yamagata, Hirotaka</au><au>Ide, Kenta</au><au>Takeshima, Masahiro</au><au>Kido, Mikio</au><au>Kikuchi, Saya</au><au>Okada, Tsuyoshi</au><au>Matsumoto, Junya</au><au>Miura, Kenichiro</au><au>Shimazu, Taichi</au><au>Inada, Ken</au><au>Watanabe, Koichiro</au><au>Hashimoto, Ryota</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study</atitle><jtitle>Psychiatry and clinical neurosciences</jtitle><addtitle>Psychiatry Clin Neurosci</addtitle><date>2023-10</date><risdate>2023</risdate><volume>77</volume><issue>10</issue><spage>559</spage><epage>568</epage><pages>559-568</pages><issn>1323-1316</issn><issn>1440-1819</issn><eissn>1440-1819</eissn><abstract>Aim
This study aims to examine the real‐world effectiveness of education regarding clinical guidelines for psychiatric disorders using ‘the Effectiveness of guidelines for dissemination and education in psychiatric treatment (EGUIDE)’ project.
Methods
The EGUIDE project is a nationwide prospective implementation study of two clinical practice guidelines, i.e., the Guideline for Pharmacological Therapy of Schizophrenia and the Treatment Guidelines for Major Depressive Disorders, in Japan. Between 2016 and 2019, 782 psychiatrists belonging to 176 hospitals with psychiatric wards participated in the project and attended lectures on clinical practice guidelines. The proportions of guideline‐recommended treatments in 7405 patients with schizophrenia and 3794 patients with major depressive disorder at participating hospitals were compared between patients under the care of psychiatrists participating in the project and those not participating in the project. Clinical and prescribing data on the patients discharged from April to September each year from participating hospitals of the project were also analyzed.
Results
The proportions of three quality indicators (antipsychotic monotherapy regardless of whether other psychotropics medication, antipsychotic monotherapy without other psychotropics and no prescription of anxiolytics or hypnotics) for schizophrenia were higher among participating psychiatrists than among nonparticipating psychiatrists. As similar results were obtained in major depressive disorder, the effectiveness of the project for the dissemination of guideline‐recommended treatment has been replicated.
Conclusion
This strategy of providing education regarding the clinical guidelines for psychiatric disorders was effective in improving the treatment‐related behavior of psychiatrists. The use of this education‐based strategy might contribute to resolving the mental health treatment gap.</abstract><cop>Melbourne</cop><pub>John Wiley & Sons Australia, Ltd</pub><pmid>37684711</pmid><doi>10.1111/pcn.13578</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-3722-7837</orcidid><orcidid>https://orcid.org/0000-0002-8253-8888</orcidid><orcidid>https://orcid.org/0000-0001-8311-7148</orcidid><orcidid>https://orcid.org/0000-0002-4414-3770</orcidid><orcidid>https://orcid.org/0000-0002-9169-3249</orcidid><orcidid>https://orcid.org/0000-0003-4228-3208</orcidid><orcidid>https://orcid.org/0000-0002-3073-4588</orcidid><orcidid>https://orcid.org/0000-0002-1145-9971</orcidid><orcidid>https://orcid.org/0000-0002-2746-1590</orcidid><orcidid>https://orcid.org/0000-0003-0614-7524</orcidid><orcidid>https://orcid.org/0000-0002-0736-7070</orcidid><orcidid>https://orcid.org/0000-0001-9417-4391</orcidid><orcidid>https://orcid.org/0000-0003-2263-3477</orcidid><orcidid>https://orcid.org/0000-0002-0809-2697</orcidid><orcidid>https://orcid.org/0000-0002-5941-4238</orcidid><orcidid>https://orcid.org/0000-0001-9577-9640</orcidid><orcidid>https://orcid.org/0000-0001-8129-4220</orcidid><orcidid>https://orcid.org/0000-0003-4409-3096</orcidid><orcidid>https://orcid.org/0000-0002-2240-5290</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1323-1316 |
ispartof | Psychiatry and clinical neurosciences, 2023-10, Vol.77 (10), p.559-568 |
issn | 1323-1316 1440-1819 1440-1819 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11488608 |
source | Wiley Online Library - AutoHoldings Journals; MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Open Access Titles of Japan; Wiley Online Library (Open Access Collection) |
subjects | Antipsychotic Agents - therapeutic use Antipsychotics Anxiolytics Clinical medicine clinical practice guideline Clinical practice guidelines Depression Depressive Disorder, Major - drug therapy dissemination education Hospitals Humans Hypnotics major depressive disorder Mental depression Mental disorders Patients Prospective Studies Psychiatrists Psychiatry Psychotropic drugs Psychotropic Drugs - therapeutic use Regular Schizophrenia Schizophrenia - drug therapy |
title | Effect of education regarding treatment guidelines for schizophrenia and depression on the treatment behavior of psychiatrists: A multicenter study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T08%3A02%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20education%20regarding%20treatment%20guidelines%20for%20schizophrenia%20and%20depression%20on%20the%20treatment%20behavior%20of%20psychiatrists:%20A%20multicenter%20study&rft.jtitle=Psychiatry%20and%20clinical%20neurosciences&rft.au=Hasegawa,%20Naomi&rft.date=2023-10&rft.volume=77&rft.issue=10&rft.spage=559&rft.epage=568&rft.pages=559-568&rft.issn=1323-1316&rft.eissn=1440-1819&rft_id=info:doi/10.1111/pcn.13578&rft_dat=%3Cproquest_pubme%3E2863294868%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2872071088&rft_id=info:pmid/37684711&rfr_iscdi=true |